EVOLENT HEALTH INC - A (EVH) Stock Analyst Ratings
NYSE:EVH • US30050B1017
2.79 USD
+0.02 (+0.72%)
At close: Feb 20, 2026
2.78 USD
-0.01 (-0.36%)
After Hours: 2/20/2026, 8:04:00 PM
ChartMill assigns a Buy % Consensus number of 84% to EVH. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 9.33. This target is 234.26% above the current price.
- EVH was analyzed by 20 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about EVH.
- In the previous month the buy percentage consensus was at a similar level.
- EVH was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-02 | BTIG | Maintains | Buy -> Buy |
| 2026-01-09 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-06 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-21 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-13 | BMO Capital | Initiate | Outperform |
| 2025-11-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-11-10 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-10 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-07 | BTIG | Maintains | Buy -> Buy |
| 2025-09-30 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-24 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2025-09-09 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-09 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-17 | Truist Securities | Maintains | Buy -> Buy |
| 2025-06-20 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-13 | Needham | Reiterate | Buy -> Buy |
| 2025-05-09 | UBS | Maintains | Buy -> Buy |
| 2025-04-28 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-10 | Truist Securities | Maintains | Buy -> Buy |
| 2025-03-10 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-24 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-02-21 | Needham | Reiterate | Buy -> Buy |
| 2025-02-21 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-02-14 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-12 | Needham | Reiterate | Buy -> Buy |
| 2025-01-28 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-24 | Oppenheimer | Maintains | Outperform -> Outperform |
EVOLENT HEALTH INC - A / EVH FAQ
Can you provide the average price target for EVOLENT HEALTH INC - A stock?
20 analysts have analysed EVH and the average price target is 9.33 USD. This implies a price increase of 234.26% is expected in the next year compared to the current price of 2.79.
How do analysts rate EVOLENT HEALTH INC - A (EVH)?
The consensus rating for EVOLENT HEALTH INC - A (EVH) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover EVOLENT HEALTH INC - A (EVH) stock?
The number of analysts covering EVOLENT HEALTH INC - A (EVH) is 20.